Lacktman Comments on the FDA’s CDS Draft Guidance

06 February 2018 MobiHealthNews News
Partner Nate Lacktman was quoted in a MobiHealthNews article, “Clinical Decision Support Coalition Letter Criticizes FDA’s Stance on CDS,” as one of the supporters of the FDA’s recent Clinical Decision Support draft guidance. This guidance outlines forms of CDS which won’t be regulated based on the degree of human involvement instead of based on risk.

Lacktman said, “Digital health companies and telemedicine providers should take a moment today and tweet a big thank you to Commissioner Scott Gottlieb (@SGottliebFDA) and the FDA for this long-awaited guidance. Not only has the FDA made great leaps to educate digital health software developers, Commissioner Gottlieb's direction clearly recognizes the need not to over-regulate our industry and instead maintain the delicate balance between protecting patient safety and promoting health innovation.”

Related Services


Hatch Comments on DNC-Related Construction Projects in Milwaukee
14 June 2019
Milwaukee Business Journal
Bernard Quoted on Debt-Relief Settlement with ITT Tech Lender
14 June 2019
Wall Street Journal
Dodd and Daughter Profiled in Wisconsin Golf
13 June 2019
Wisconsin Golf
Brinckerhoff Comments on SCOTUS Ruling in Patent Case
11 June 2019
Intellectual Property Magazine
Review of 2020 Medicare Changes for Telehealth
11 December 2019
Member Call
2019 NDI Executive Exchange
14-15 November 2019
Chicago, IL
Association for Corporate Counsel Annual Meeting 2019
27-30 October 2019
Phoenix, AZ
Foley's Government Contracts Annual Update
16 October 2019
Liviona, MI